Journal of Antimicrobial Chemotherapy

Leading articles:

AP Fraise

Guidelines for the control of methicillin-resistant Staphylococcus aureus
J. Antimicrob. Chemother. 1998 42: 287-289; doi:10.1093/jac/42.3.287 [PDF] [Request Permissions]  

Original articles:

AP Johnson

Intermediate vancomycin resistance in Staphylococcus aureus: a major threat or a minor inconvenience?
J. Antimicrob. Chemother. 1998 42: 289-291; doi:10.1093/jac/42.3.289 [PDF] [Request Permissions]  

DC Shanson

New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis
J. Antimicrob. Chemother. 1998 42: 292-296; doi:10.1093/jac/42.3.292 [PDF] [Request Permissions]  

T Schulin, CB Wennersten, RC Moellering, Jr, and GM Eliopoulos

In-vitro activity of the new ketolide antibiotic HMR 3647 against gram- positive bacteria
J. Antimicrob. Chemother. 1998 42: 297-301; doi:10.1093/jac/42.3.297 [Abstract] [PDF] [Request Permissions]  

AF Maggs, JM Logan, PE Carter, and TH Pennington

The detection of penicillin insensitivity in Neisseria meningitidis by polymerase chain reaction
J. Antimicrob. Chemother. 1998 42: 303-307; doi:10.1093/jac/42.3.303 [Abstract] [PDF] [Request Permissions]  

M Lopez-Brea, D Domingo, I Sanchez, N Prieto, and T Alarcon

Study of the combination of ranitidine bismuth citrate and metronidazole against metronidazole-resistant Helicobacter pylori clinical isolates
J. Antimicrob. Chemother. 1998 42: 309-314; doi:10.1093/jac/42.3.309 [Abstract] [PDF] [Request Permissions]  

H Hanaki, H Labischinski, Y Inaba, N Kondo, H Murakami, and K Hiramatsu

Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50
J. Antimicrob. Chemother. 1998 42: 315-320; doi:10.1093/jac/42.3.315 [Abstract] [PDF] [Request Permissions]  

B Pradines, A Tall, D Parzy, A Spiegel, T Fusai, R Hienne, JF Trape, and JC Doury

In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents
J. Antimicrob. Chemother. 1998 42: 333-339; doi:10.1093/jac/42.3.333 [Abstract] [PDF] [Request Permissions]  

K Izumikawa, Y Hirakata, T Yamaguchi, H Takemura, S Maesaki, K Tomono, S Igimi, M Kaku, Y Yamada, S Kohno, and S Kamihira

Escherichia coli O157 interactions with human intestinal Caco-2 cells and the influence of fosfomycin
J. Antimicrob. Chemother. 1998 42: 341-347; doi:10.1093/jac/42.3.341 [Abstract] [PDF] [Request Permissions]  

C Meyerhoff, C Dilger, SJ Yoon, YH Chung, DK Lee, CW Lee, JM Ryu, MS Choi, G Pabst, and C Reh

Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects
J. Antimicrob. Chemother. 1998 42: 349-361; doi:10.1093/jac/42.3.349 [Abstract] [PDF] [Request Permissions]  

SE Parker, D Nathwani, D O'Reilly, S Parkinson, and PG Davey

Evaluation of the impact of non-inpatient i.v. antibiotic treatment for acute infections on the hospital, primary care services and the patient
J. Antimicrob. Chemother. 1998 42: 373-380; doi:10.1093/jac/42.3.373 [Abstract] [PDF] [Request Permissions]  

B Sener and A Gunalp

Trends in antimicrobial resistance of Streptococcus pneumoniae in children in a Turkish hospital
J. Antimicrob. Chemother. 1998 42: 381-384; doi:10.1093/jac/42.3.381 [Abstract] [PDF] [Request Permissions]  

J Guarro, I Pujol, C Aguilar, C Llop, and J Fernandez-Ballart

Inoculum preparation for in-vitro susceptibility testing of filamentous fungi
J. Antimicrob. Chemother. 1998 42: 385-387; doi:10.1093/jac/42.3.385 [Abstract] [PDF] [Request Permissions]  

PE Verweij, M Mensink, AJ Rijs, JP Donnelly, JF Meis, and DW Denning

In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates
J. Antimicrob. Chemother. 1998 42: 389-392; doi:10.1093/jac/42.3.389 [Abstract] [PDF] [Request Permissions]  

B Sadaba, A Lopez de Ocariz, JR Azanza, J Quiroga, and JA Cienfuegos

Concurrent clarithromycin and cyclosporin A treatment
J. Antimicrob. Chemother. 1998 42: 393-395; doi:10.1093/jac/42.3.393 [Abstract] [PDF] [Request Permissions]  

L Massias, C Muller-Serieys, R Farinotti, and E Bergogne-Berezin

Pharmacokinetics of cefuroxime in healthy volunteers: an update
J. Antimicrob. Chemother. 1998 42: 408-410. [Request Permissions]  

Reviews:

DW Warnock, EM Johnson, and TR Rogers

Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy
J. Antimicrob. Chemother. 1998 42: 321-331; doi:10.1093/jac/42.3.321 [Abstract] [PDF] [Request Permissions]  

W Brumfitt and JM Hamilton-Miller

Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience
J. Antimicrob. Chemother. 1998 42: 363-371; doi:10.1093/jac/42.3.363 [Abstract] [PDF] [Request Permissions]  

Letters:

R Vanhoof

Comparative in-vitro activities of amoxycillin and penicillin against Streptococcus pneumoniae isolates
J. Antimicrob. Chemother. 1998 42: 397-398; doi:10.1093/jac/42.3.397 [PDF] [Request Permissions]  

SG Amyes and CJ Thomson

Fluoroquinolones as treatment for patients with lower respiratory tract infections caused by Streptococcus pneumoniae
J. Antimicrob. Chemother. 1998 42: 398-399; doi:10.1093/jac/42.3.398 [PDF] [Request Permissions]  

PM Shah

Ciprofloxacin prophylaxis and therapy of Yersinia pestis infection
J. Antimicrob. Chemother. 1998 42: 399a; doi:10.1093/jac/42.3.399a [PDF] [Request Permissions]  

AT Bouthors, V Jarlier, and W Sougakoff

Amino acid substitutions at positions 69, 165, 244 and 275 of the PER- 1beta-lactamase do not impair enzyme inactivation by clavulanate
J. Antimicrob. Chemother. 1998 42: 399b-401b; doi:10.1093/jac/42.3.399b [PDF] [Request Permissions]  

Z Pragai, Z Koczian, and E Nagy

Characterization of the extended-spectrum beta-lactamases and determination of the antibiotic susceptibilities of Klebsiella pneumoniae isolates in Hungary
J. Antimicrob. Chemother. 1998 42: 401-403; doi:10.1093/jac/42.3.401 [PDF] [Request Permissions]  

JE Finlay, LA Miller, and JA Poupard

Comparison of the 5 microg disc and the Neo-Sensitab for determining the susceptibilities of Staphylococcus aureus isolates to mupirocin
J. Antimicrob. Chemother. 1998 42: 403-405; doi:10.1093/jac/42.3.403 [PDF] [Request Permissions]  

JA Washington and D Felmingham

The in-vitro activities of co-amoxiclav and other oral antibiotics against Streptococcus pneumoniae isolates exhibiting intermediate susceptibility to penicillin
J. Antimicrob. Chemother. 1998 42: 405-406; doi:10.1093/jac/42.3.405 [PDF] [Request Permissions]  

P Wilson, C Koshy, and M Minassian

An LY333328-dependent strain of Enterococcus faecalis isolated from a blood culture
J. Antimicrob. Chemother. 1998 42: 406-407; doi:10.1093/jac/42.3.406 [PDF] [Request Permissions]  

AO De Souza, DC Aily, DN Sato, and N Duran

In-vitro activity of N,N-dimethyl-2-propen-1-amines against Mycobacterium tuberculosis
J. Antimicrob. Chemother. 1998 42: 407-408; doi:10.1093/jac/42.3.407 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.